Patent: 9,873,667
✉ Email this page to a colleague
Summary for Patent: 9,873,667
Title: | Arylsulfanyl compounds and compositions for delivering active agents |
Abstract: | Compounds and compositions for the delivery of active agents are provided. Methods of administration and preparation are also provided. |
Inventor(s): | Pusztay; Stephen (Ansonia, CT), Saraf; Sushma (Wappingers Falls, NY), Wang; Nai Fang (Scarsdale, NY) |
Assignee: | EMISPHERE TECHNOLOGIES INC. (Roseland, NJ) |
Application Number: | 12/375,369 |
Patent Claims: | see list of patent claims |
Details for Patent 9,873,667
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Eli Lilly And Company | HUMULIN R U-100 | insulin human | Injection | 018780 | 10/28/1982 | ⤷ Try a Trial | 2026-07-27 |
Eli Lilly And Company | HUMULIN R U-500 | insulin human | Injection | 018780 | 12/29/2015 | ⤷ Try a Trial | 2026-07-27 |
Eli Lilly And Company | HUMULIN R U-100 | insulin human | Injection | 018780 | 08/06/1998 | ⤷ Try a Trial | 2026-07-27 |
Eli Lilly And Company | HUMULIN R U-500 | insulin human | Injection | 018780 | 03/31/1994 | ⤷ Try a Trial | 2026-07-27 |
Eli Lilly And Company | HUMULIN R U-100 | insulin human | Injection | 018780 | 05/25/2018 | ⤷ Try a Trial | 2026-07-27 |
Novo Nordisk Inc. | NOVOLIN R | insulin human | Injection | 019938 | 06/25/1991 | ⤷ Try a Trial | 2026-07-27 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |